Global demand for third-party logistics (3PL) in the biopharmaceutical sector is set to accelerate, driven by advanced temperature management technologies, sustainability initiatives, and the expansion of biologics manufacturing worldwide.
According to a new report from InsightAce Analytic Pvt. Ltd., the global biopharmaceutical third-party logistics market is projected to reach USD 264.8 billion by 2034, growing at a compound annual growth rate (CAGR) of 6.6% between 2025 and 2034.
Key Market Drivers
-
Technological Advancements: The integration of warehouse robotics, IoT-enabled monitoring, data analytics, and mobile cloud solutions is transforming logistics performance and temperature control precision.
-
Rising Cold Chain Demand: As vaccines, biologics, and temperature-sensitive drugs expand globally, 3PL providers are prioritizing cold chain capabilities, with over 60% identifying it as central to their future growth.
-
Sustainability Commitments: The sector is also embracing green logistics, deploying energy-efficient fleets, recyclable packaging, and emissions-reducing technologies to meet environmental goals.
The non-cold chain segment currently accounts for the largest market share — 81.3% as of 2020 — but analysts forecast faster growth ahead in the cold chain sector, driven by biologics and advanced therapies requiring precise temperature management.
Regional Outlook
North America dominated the market in 2022 with over 42% share, supported by robust pharmaceutical exports, advanced healthcare infrastructure, and the presence of major logistics providers. Pharmaceutical firms across the U.S. and Canada continue to rely heavily on 3PL partners to optimize warehousing, regulatory compliance, and cross-border transport.
Meanwhile, Asia-Pacific is expected to be the fastest-growing region, fueled by expanding biomanufacturing hubs in China, India, and South Korea, alongside increased investment in temperature-controlled logistics networks.
Industry Landscape
Leading players in the market include:
DHL International GmbH, UPS Healthcare, SF Express, AmerisourceBergen Corp., DB Schenker, Kuehne + Nagel, Agility, and Kerry Logistics.
Recent consolidation trends continue to shape the competitive landscape:
-
In May 2022, Hitachi Transport System acquired Czech logistics provider Vlkova Partners, expanding its European presence.
-
In March 2022, ST Logistics strengthened its North American footprint by acquiring the intermodal division of XPO Logistics, a leading container transport operator.
Market Segmentation Snapshot
-
By Supply Chain: Cold Chain, Non-Cold Chain
-
By Service Type: Transportation (Air, Sea, Overland), Warehousing & Storage, Other Services
-
By Region: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
The study underscores how technological integration and sustainability are redefining biopharma logistics — shifting the industry toward resilient, digitally connected, and environmentally responsible operations.
